Cargando…

Whole-genome sequencing for surveillance of fluoroquinolone resistance in rifampicin-susceptible tuberculosis in a rural district of Shanghai: A 10-year retrospective study

BACKGROUND: Fluoroquinolones (FQs) are the most important second-line anti-tuberculosis (anti-TB) drugs, primarily used for the treatment of multidrug- or rifampicin-resistant TB (MDR/RR-TB). However, FQs are also commonly used to treat other bacterial infections. There are few published data on the...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Yangyi, Jiang, Yuan, Yu, Chenlei, Li, Jing, Shen, Xuhui, Pan, Qichao, Shen, Xin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Public Health
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9521709/ https://www.ncbi.nlm.nih.gov/pubmed/36187694 http://dx.doi.org/10.3389/fpubh.2022.990894

Ejemplares similares

A Whole-Genome Sequencing-Based Study to Delineate the Risk and Characteristics of Tuberculosis Transmission in an Insular Population Over 10 Years in Shanghai
por: Wang, Min, et al.
Publicado: (2022)

Effect of the Xpert MTB/RIF on the detection of pulmonary tuberculosis cases and rifampicin resistance in Shanghai, China
por: Wu, Zheyuan, et al.
Publicado: (2020)

Effect of mobile health reminders on tuberculosis treatment outcomes in Shanghai, China: A prospective cohort study
por: Wu, Zheyuan, et al.
Publicado: (2023)

Genotypic and spatial analysis of transmission dynamics of tuberculosis in Shanghai, China: a 10-year prospective population-based surveillance study
por: Li, Meng, et al.
Publicado: (2023)

Predicting resistance to fluoroquinolones among patients with rifampicin-resistant tuberculosis using machine learning methods
por: You, Shiying, et al.
Publicado: (2022)

Identification and Characterization of Fluoroquinolone Non-susceptible Streptococcus pyogenes Clones Harboring Tetracycline and Macrolide Resistance in Shanghai, China
por: Shen, Yinfang, et al.
Publicado: (2018)

Increase in Nontuberculous Mycobacteria Isolated in Shanghai, China: Results from a Population-Based Study
por: Wu, Jie, et al.
Publicado: (2014)

Spatial analysis of tuberculosis treatment outcomes in Shanghai: implications for tuberculosis control
por: Zhang, Jing, et al.
Publicado: (2022)

Geographical Variation of COPD Mortality and Related Risk Factors in Jiading District, Shanghai
por: Peng, Qian, et al.
Publicado: (2021)

Bedaquiline can act as core drug in a standardised treatment regimen for fluoroquinolone-resistant rifampicin-resistant tuberculosis
por: Decroo, Tom, et al.
Publicado: (2022)

Comparison of newly diagnosed COPD patients and the non-COPD residents in Shanghai Minhang District
por: Yin, Xin, et al.
Publicado: (2023)

Evaluation of whole-genome sequence to predict drug resistance of nine anti-tuberculosis drugs and characterize resistance genes in clinical rifampicin-resistant Mycobacterium tuberculosis isolates from Ningbo, China
por: Che, Yang, et al.
Publicado: (2022)

Recurrence Is a Noticeable Cause of Rifampicin-Resistant Mycobacterium tuberculosis in the Elderly Population in Jiangxi, China
por: Chen, Qiang, et al.
Publicado: (2019)

Estimation of the Rural Dog Population Within a Mega-City: An Example in Jiading District, Shanghai
por: Wu, Xiujuan, et al.
Publicado: (2021)

Fluoroquinolone susceptibility in first-line drug-susceptible M. tuberculosis isolates in Lima, Peru
por: Schwalb, Alvaro, et al.
Publicado: (2021)

Low Frequency of Acquired Isoniazid and Rifampicin Resistance in Rifampicin-Susceptible Pulmonary Tuberculosis in a Setting of High HIV-1 Infection and Tuberculosis Coprevalence
por: Rockwood, Neesha, et al.
Publicado: (2017)

Recurrent Tuberculosis and Exogenous Reinfection, Shanghai, China
por: Shen, Guomiao, et al.
Publicado: (2006)

Susceptibility Profiles of Mycobacterium ulcerans Isolates to Streptomycin and Rifampicin in Two Districts of the Eastern Region of Ghana
por: Owusu, Enid, et al.
Publicado: (2016)

Could high-concentration rifampicin kill rifampicin-resistant M. tuberculosis? Rifampicin MIC test in rifampicin-resistant isolates from patients with osteoarticular tuberculosis
por: Zhang, Zehua, et al.
Publicado: (2014)

Surveillance for multi-drug and rifampicin resistant tuberculosis and treatment outcomes among previously treated persons with tuberculosis in the era of GeneXpert in rural eastern Uganda
por: Izudi, Jonathan, et al.
Publicado: (2020)

High-Dose First-Line Treatment Regimen for Recurrent Rifampicin-Susceptible Tuberculosis
por: Decroo, Tom, et al.
Publicado: (2020)

Successful Outcomes with Oral Fluoroquinolones Combined with Rifampicin in the Treatment of Mycobacterium ulcerans: An Observational Cohort Study
por: O'Brien, Daniel P., et al.
Publicado: (2012)

Association of gyrA/B mutations and resistance levels to fluoroquinolones in clinical isolates of Mycobacterium tuberculosis
por: Li, Jing, et al.
Publicado: (2014)

Airway microecology in rifampicin-resistant and rifampicin-sensitive pulmonary tuberculosis patients
por: Cai, Xingshan, et al.
Publicado: (2022)

Treatment Outcomes of Isoniazid-Resistant (Rifampicin Susceptible) Tuberculosis Patients in Uzbekistan, 2017–2018
por: Sayfutdinov, Zayniddin, et al.
Publicado: (2021)

Transmission of multidrug-resistant tuberculosis in Shimen community in Shanghai, China: a molecular epidemiology study
por: Han, Zhiying, et al.
Publicado: (2021)

Association of Daily Exposure to Air Pollutants with the Risk of Tuberculosis in Xuhui District of Shanghai, China
por: Xiong, Ying, et al.
Publicado: (2022)

Stillbirth surveillance and review in rural districts in Bangladesh
por: Halim, Abdul, et al.
Publicado: (2018)

Correlation of different phenotypic drug susceptibility testing methods for four fluoroquinolones in Mycobacterium tuberculosis
por: Coeck, Nele, et al.
Publicado: (2016)

Does empirical treatment of community-acquired pneumonia with fluoroquinolones delay tuberculosis treatment and result in fluoroquinolone resistance in Mycobacterium tuberculosis? Controversies and solutions
por: Shen, Gwan-Han, et al.
Publicado: (2012)

Primary Rifampicin Mono-Resistant Extrapulmonary Tuberculosis of the Knee Without Pulmonary Involvement: One of the First Cases of Its Type in an Immunocompetent Male
por: Yadav, Sankalp
Publicado: (2023)

The impact of vaccination on patients with COVID-19 during the wave of Omicron in Shanghai
por: Yu, Chen, et al.
Publicado: (2022)

10-Year Molecular Surveillance of Listeria monocytogenes Using Whole-Genome Sequencing in Shanghai, China, 2009–2019
por: Zhang, Hongzhi, et al.
Publicado: (2020)

High fluoroquinolone MIC is associated with fluoroquinolone treatment failure in urinary tract infections caused by fluoroquinolone susceptible Escherichia coli
por: Rattanaumpawan, Pinyo, et al.
Publicado: (2017)

Configuration paths of community cafe to enhance residents’ well-being: fsQCA analysis of 20 cases in Shanghai
por: Zhang, Man, et al.
Publicado: (2023)

Transmission of MDR and XDR Tuberculosis in Shanghai, China
por: Zhao, Ming, et al.
Publicado: (2009)

Resistance to Second-Line Antituberculosis Drugs and Delay in Drug Susceptibility Testing among Multidrug-Resistant Tuberculosis Patients in Shanghai
por: Chen, Yong, et al.
Publicado: (2016)

Pyrazinamide resistance in rifampicin discordant tuberculosis
por: Mvelase, Nomonde Ritta, et al.
Publicado: (2022)

Blood Agar Validation for Susceptibility Testing of Isoniazid, Rifampicin, Ethambutol, and Streptomycin to Mycobacterium tuberculosis Isolates
por: Coban, Ahmet Yilmaz
Publicado: (2013)

High Isoniazid Resistance Rates in Rifampicin Susceptible Mycobacterium tuberculosis Pulmonary Isolates from Pakistan
por: Fasih, Naima, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_bl2q7ja7uijrl0t8sjcg5jafs6